Live Chat

Live Chat

BD Phoenix M50 instrument

Delivering performance, connectivity and functionality required by clinical microbiology laboratories

The BD Phoenix M50 instrument provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions.

Trusted performance

The BD Phoenix system provides on-panel doubling dilutions and built-in detection resistance, including CPO, MRSA, mecA, VRSA, VRE, ESBL, HLAR, and iMLSb*.

Scalability

The instrument is compact and stackable, allowing for increased testing volumes by doubling capacity within the same footprint.

Ease of use

The system requires no reagent additions post inoculation and few supplemental tests for final result determination, while utilizing leak-resistant, room-temperature panel storage. 

Advanced data management

The BD EpiCenter data management system interfaces with the BD Phoenix M50 and provides intuitive, on-demand antibiogram generation and flexible reporting options.

*Depending on BD Phoenix panel type and organism identification.

Dual growth detection technology

The BD Phoenix™ M50 instrument determines growth using both an oxidation-reduction indicator and turbidity growth detection to help provide both rapid and accurate susceptibility results.


True doubling dilutions

The BD Phoenix system utilizes on-panel doubling dilutions of antimicrobial concentrations for determination of MIC results.


Delayed growth algorithm

The BD Phoenix M50 instrument employs a delayed growth algorithm that may defer reporting for slow-growing organisms until additional instrument readings are collected. This feature enables an accurate determination of growth or no-growth, providing additional assurance that results are accurate.


Resistance detection

The BD Phoenix system provides on-panel doubling dilutions of antimicrobials and built-in detection of resistance, including CPO, MRSA, mecA, VRSA, VRE, ESBL, HLAR, and iMLSb*.

*Depending on BD Phoenix panel type and organism identification.


Robust, customizable data management

The BD EpiCenter™ data management system offers the BDXpert system, which implements CLSI breakpoints and SIR interpretations. BD EpiCARE™ is an optional extension of the BD EpiCenter system that gives users the ability to define customized rules and actions to ensure compliance for the reporting of microbiology data that may be specific to their organization.


Modular and scalable

The BD Phoenix M50 instrument offers a compact and stackable design (up to two instruments) that allows for increased testing volumes by doubling capacity within the same footprint.


Ease of use

The system requires minimal maintenance, no reagent additions post inoculation and few supplemental tests for final result determination, and utilizes leak-resistant, room-temperature panel storage.


Automated inoculation preparation

The BD Phoenix AP automated inoculation preparation instrument may help to reduce sample preparation workflow burdens, reducing total hands-on time per sample by 50% compared to manual BD Phoenix preparation and by an average of 20% compared to selected competitive products. 1-2


Microorganism identification

  • The BD Phoenix™ M50 system instrument offers identification-only panels and combination ID/AST panels, using 51 wells for identification substrates.
  • The system can provide rapid identification of most clinically significant Gram-negative and Gram- positive bacteria, as well as yeast.

Susceptibility testing

  • The BD Phoenix M50 system offers 85 wells for antimicrobial dilutions on standard AST-only panels and combination ID/AST panels, and 136 wells on the BD Phoenix™ Emerge™ panel.
  • The instrument can provide rapid susceptibility results for most clinically significant Gram-negative and Gram-positive bacteria.
  • The BD Phoenix M50 system panels test for several resistance markers*such as**:
    • Gram-positive bacteria
      • HLAR—High Level Aminoglycoside Resistant Enterococcus
      • iMLSb—Inducible Clindamycin Resistance
      • MRSA—based on Oxacillin Interpretation with Staphylococcus species
      • mecA – detection of mecA-medicated resistance in Staphylococcus aureus
      • BL- Staphylococcus ß-Lactamase (Nitrocefin based test)
      • VRSA—Vancomycin-Resistant Staphylococcus Aureus
      • VRE—based on Vancomycin interpretation
    • Gram-negative bacteria
      • CPO—Carbapenemase Producing Organism
      • ESBL—offered on Gram-negative panels and requires no additional disc diffusion or E-Test confirmation.

* Depending on BD Phoenix panel type and organism identification


Detecting CPOs

  • The BD Phoenix CPO detect test, available on certain BD Phoenix Gram-negative panels, provides information, including Ambler classification, to help guide clinicians in their treatment decisions.
  • This test is available in two-panel configurations that allow microbiology labs to test for CPOs as part of routine susceptibility testing on BD Phoenix panels:
    • 2-well configuration—provides detection of Carbapenemase-producing organisms in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii
    • 9-well configuration—provides detection of carbapenemase-producing organisms and Ambler classification (A, B or D) in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii
  • The BD Phoenix CPO detect test is currently the only phenotypic test on an automated AST system that provides CPO detection and Ambler classification.
  • On average, the BD Phoenix CPO detect test detects and classifies CPOs from isolated colonies within 6 to 11 hours.**

 **BD internal studies—data on file


Ordering information
Catalog no. Description Quantity (each)
443624 BD Phoenix™ M50 instrument 1
443625 BD Phoenix™ M50 instrument starter kit 1

Accessories

Related Products



Reference
  1. Junkins A, et al. Comparison of BD Phoenix AP Workflow with Vitek 2. J. Clin. Microbiol. 2010. 48 (5): 1929-1931. Study was supported by grants from BD Diagnostic Systems.
  2. Jungkind D, et al. Workflow evaluation of the BD Phoenix AP Compared to the MicroScan Walkaway overnight system for identification and susceptibility testing of bacteria. As presented at the 110th General Meeting of the American Society of Microbiology. May 2010. Study was supported by grants from BD Diagnostic Systems.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.